Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
2022-11-29 11:35:0 am ADC Therapeutics: Running Through A Stretch Of Bad Luck SeekingAlpha
2022-11-28 6:47:0 am Biocytogen Enters into Antibody Agreement with ADC Therapeutics Business Wire
2022-11-16 4:5:19 am The past year for ADC Therapeutics (NYSE:ADCT) investors has not been profitable Simply Wall St.
2022-11-08 5:15:1 am ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates Zacks
2022-11-08 4:0:0 am ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates Business Wire
2022-11-07 4:15:0 am ADC Therapeutics to Participate in the Jefferies London Healthcare Conference Business Wire
2022-11-04 2:46:9 am Arcturus Therapeutics (ARCT) Surges 18.7%: Is This an Indication of Further Gains? Zacks
2022-11-03 6:34:0 am ADC Therapeutics Announces Abstracts Accepted for Presentation at the 64th ASH Annual Meeting Business Wire
2022-11-02 1:5:0 pm IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma GlobeNewswire